Crucell Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,300

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.39B

  • Investors
  • 1

Crucell General Information

Description

Operator of a global biopharmaceutical company intended to focus on research development, production, and marketing of vaccines, proteins, and antibodies that prevent and treat infectious diseases. The company focuses on developing, producing, and marketing products that combat infectious diseases in pre-clinical and clinical development.

Contact Information

Website
www.crucell.com
Formerly Known As
IntroGene
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • P.O. BOX 2048
  • Leiden
  • Netherlands
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Johnson & Johnson
Vertical(s)
Life Sciences
Corporate Office
  • P.O. BOX 2048
  • Leiden
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Crucell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 22-Feb-2011 $2.39B Completed Profitable
3. IPO 27-Oct-2000 Completed Generating Revenue
2. Later Stage VC Completed Generating Revenue
1. University Spin-Out 01-Jan-1993 Completed Startup
To view Crucell’s complete valuation and funding history, request access »

Crucell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a global biopharmaceutical company intended to focus on research development, production, and marketing of v
Biotechnology
Leiden, Netherlands
1,300 As of 2023

Bengaluru, India
 

Tokyo, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Crucell Competitors (55)

One of Crucell’s 55 competitors is Biocon, a Formerly PE-Backed company based in Bengaluru, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocon Formerly PE-Backed Bengaluru, India
Astellas Pharma Corporation Tokyo, Japan
Genfit Formerly VC-backed Loos, France
Merck & Co. Corporation Rahway, NJ
KBI BioPharma Formerly VC-backed Durham, NC
You’re viewing 5 of 55 competitors. Get the full list »

Crucell Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Crucell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060121580-A1 Detecting a severe acute respiratory syndrome coronavirus (sars-co-v); Active 22-Jul-2003

Crucell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crucell Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alta Partners Venture Capital Minority
Atlas Venture Venture Capital Minority
EQT Life Sciences Venture Capital Minority
Forbion Venture Capital Minority
Gimv PE/Buyout Minority
You’re viewing 5 of 9 investors. Get the full list »

Crucell Investments & Acquisitions (6)

Crucell’s most recent deal was a Merger/Acquisition with Crucell Sweden for . The deal was made on 23-Nov-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Crucell Sweden 23-Nov-2006 Merger/Acquisition Biotechnology
Berna Biotech 01-Jan-2006 Merger/Acquisition Drug Discovery
Galapagos (Biotechnology) 05-Mar-2002 Early Stage VC Biotechnology
U-Bisys 30-Jun-2000 Merger/Acquisition Drug Discovery
Galapagos (Biotechnology) 01-Jan-1999 Joint Venture Biotechnology
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Crucell FAQs

  • When was Crucell founded?

    Crucell was founded in 1993.

  • Where is Crucell headquartered?

    Crucell is headquartered in Leiden, Netherlands.

  • What is the size of Crucell?

    Crucell has 1,300 total employees.

  • What industry is Crucell in?

    Crucell’s primary industry is Biotechnology.

  • Is Crucell a private or public company?

    Crucell is a Private company.

  • What is the current valuation of Crucell?

    The current valuation of Crucell is .

  • What is Crucell’s current revenue?

    The current revenue for Crucell is .

  • Who are Crucell’s investors?

    Alta Partners, Atlas Venture, EQT Life Sciences, Forbion, and Gimv are 5 of 9 investors who have invested in Crucell.

  • Who are Crucell’s competitors?

    Biocon, Astellas Pharma, Genfit, Merck & Co., and KBI BioPharma are some of the 55 competitors of Crucell.

  • When was Crucell acquired?

    Crucell was acquired on 22-Feb-2011.

  • Who acquired Crucell?

    Crucell was acquired by Johnson & Johnson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »